Institutional investors hold a majority ownership of CELG through the 80.04% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BNP PARIBAS ARBITRAGE SNC Bought 192.3 Thousand shares of Celgene
MEDIOLANUM ASSET MANAGEMENT LTD. Bought 138.5 Thousand shares of Celgene
JOHN W. BRISTOL & CO., INC. (NEW... Bought 118.5 Thousand shares of Celgene